Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting

被引：0
|
作者：
Marie-Theres Kassik
Dirk Vordermark
Christine Kornhuber
Daniel Medenwald
机构：
[1] University Hospital Halle/Saale,Department of Radiation Therapy
来源：
Radiation Oncology | / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting
    Kassik, Marie-Theres
    Vordermark, Dirk
    Kornhuber, Christine
    Medenwald, Daniel
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [2] Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non-Small Cell Lung Cancer Trials Using Real-World Data
    Ton, Thanh G. N.
    Pal, Navdeep
    Trinh, Huong
    Mahrus, Sami
    Bretscher, Michael T.
    Machado, Robson J. M.
    Sadetsky, Natalia
    Chaudhary, Nayan
    Lu, Michael W.
    Riely, Gregory J.
    CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2844 - 2853
  • [3] REAL-WORLD PROGRESSION-FREE AND OVERALL SURVIVAL OF ADVANCED NON-SMALL-CELL LUNG CANCER PATIENTS: ANALYSIS BASED ON A NEW GERMAN EMR DATASET
    Wilke, T.
    Dittmar, A.
    Mueller, S.
    Juhl, H.
    VALUE IN HEALTH, 2019, 22 : S884 - S884
  • [4] REAL-WORLD PROGRESSION-FREE SURVIVAL BY TIMING OF MOLECULAR PROFILING TESTING AMONG METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS IN A COMMUNITY SETTING
    Liu, S.
    DeClue, R.
    Nisbett, A.
    Gautam, S.
    Fisher, M. D.
    Shenolikar, R.
    VALUE IN HEALTH, 2021, 24 : S24 - S24
  • [5] Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
    Imai, Hisao
    Mori, Keita
    Wakuda, Kazushige
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    ANNALS OF THORACIC MEDICINE, 2015, 10 (01) : 61 - 66
  • [6] Predicting real-world effectiveness using overall survival and progression-free survival-based clinical trial efficacy measures
    Shafrin, Jason
    Hou, Ningqi
    Brookmeyer, Ron
    Peneva, Desi
    Vine, Seanna
    Park, Jinhee
    Zhang, Jie
    Figlin, Robert A.
    Lakdawalla, Darius N.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] REAL-WORLD PROGRESSION-FREE AND OVERALL SURVIVAL OF METASTATIC BREAST CANCER PATIENTS: ANALYSIS OF A NEW GERMAN EMR DATASET
    Wilke, T.
    Dittmar, A.
    Mueller, S.
    Juhl, H.
    VALUE IN HEALTH, 2019, 22 : S535 - S535
  • [8] Progression-free survival as a predictor of overall survival in patients with advanced breast cancer: A real-world study from the China National Cancer Center.
    Mo, Hongnan
    Xu, Binghe
    Ma, Fei
    Li, Qing
    Zhang, Pin
    Yuan, Peng
    Wang, Jiayu
    Luo, Yang
    Cai, Ruigang
    Li, Qiao
    Li, Yiqun
    Guan, Xiuwen
    Lin, Shaoyan
    Chen, Yimeng
    Wang, Zijing
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] BASELINE POPULATION CHARACTERISTICS AND THE ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ADVANCED NON SMALL CELL LUNG CANCER PATIENTS
    Kulakova, M.
    Hashim, M.
    Pfeiffer, B.
    Postma, M.
    Heeg, B.
    VALUE IN HEALTH, 2017, 20 (09) : A420 - A421
  • [10] Correlations between overall response rate, progression-free survival and overall survival in refractory small cell lung cancer treated with lurbinectedin
    Wasifuddin, Mustafa
    Ilerhunmwuwa, Nosakhare Paul
    Hakobyan, Narek
    Tahir, Muhammad
    Abowali, Hesham
    Avezbakiyev, Boris
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345